Usability and Feasibility of the NutriQuest Application (NCT05884489) | Clinical Trial Compass
CompletedNot Applicable
Usability and Feasibility of the NutriQuest Application
Belgium21 participantsStarted 2022-06-01
Plain-language summary
The study is a pilot study (phase 2) that includes a usability study (phase 1).
The aim of the study is to investigate the feasibility and usability of the healthy nutrition application and the effects on adherence to Modified Mediterranean diet, self-efficacy and nutrition knowledge among patients with cardiovascular disease in a cardiac rehabilitation setting. Furthermore, it studies the overall user experience when using the healthy nutrition application.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* History of cardiovascular disease with or without intervention (PCI/CABG/conservative/pacemaker implantation/ablation)
* History of current or past cardiac rehabilitation in Jessa Hospital Hasselt
* Current treatment must require them to follow the Mediterranean diet plan
* Age ≥18 years
* Willing and physically able to follow a application-based healthy nutrition program and other study procedures in a six-week follow-up period
* Evidence of a personally signed and dated informed consent, indicating that the subject (or a legally-recognized representative) has been informed of all pertinent aspects of the study
* Possession of and/or able to use an Android based smartphone (version 6 or higher)
* Possession of internet connectivity
* Dutch speaking and understanding
Exclusion Criteria:
* Pregnant females
* Combined with diabetes or severe kidney disease
* Participation in other cardiac rehabilitation program trials, focusing on diet outcome
* Current or recent participation in other technology-supported programs, even when not directly targeting nutrition
* Any condition which in the opinion of the investigator would make it unsafe or unsuitable for the patient to participate in this study or a life expectancy of less than six weeks based on investigators judgment
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.